Cannabidiol prescribing in the United States: An analysis of real-world data

  • 0Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, United States.

|

|

Summary

This summary is machine-generated.

Off-label Epidiolex® (pharmaceutical cannabidiol) prescribing is common, with 40% of patients lacking FDA-approved indications. Concurrent use of interacting medications, particularly psychotropics, is also prevalent, necessitating further study on patient outcomes.

Area Of Science

  • Pharmacology
  • Neurology
  • Public Health

Background

  • Off-label prescribing of Epidiolex® (pharmaceutical cannabidiol) presents potential benefits and risks.
  • Understanding prescribing patterns and potential drug interactions is crucial for patient safety.

Purpose Of The Study

  • To determine the percentage of patients prescribed Epidiolex® without FDA-approved indications (Lennox Gastaut Syndrome [LGS], Dravet Syndrome [DS], Tuberous Sclerosis Complex [TSC]).
  • To examine the co-prescription of medications known to interact with Epidiolex®.

Main Methods

  • Analysis of de-identified electronic health records from TriNetX, a database of over 110 million US individuals.
  • Inclusion of 4214 patients who received Epidiolex® in 2022.
  • Evaluation of diagnoses and co-prescribed medications relative to Epidiolex® initiation.

Main Results

  • 40% of patients receiving Epidiolex® lacked documented FDA-approved indications (LGS/DS/TSC).
  • High prevalence of co-prescribed psychotropic medications with known cannabidiol interactions (e.g., Clobazam, Diazepam, Clonazepam).
  • Common post-prescription diagnoses in the off-label group included unspecified epileptic syndromes, sleep, anxiety, mood disorders, and autism spectrum disorder.

Conclusions

  • Off-label Epidiolex® prescribing and co-prescription of interacting medications are prevalent.
  • Further research is required to understand the long-term outcomes of off-label Epidiolex® use.

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs 01:02

687

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

Analysis of Population Pharmacokinetic Data 01:12

224

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Drug Control Governance: Regulatory Bodies and Their Impact 01:03

141

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...

Pharmacovigilance 01:19

773

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids 01:21

201

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Drug Classes and Categories 01:25

1.9K

Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...